Home › Trial NCT00988884
A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)
- Trial IDNCT00988884
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorMerck Sharp & Dohme LLC
- Enrollment1241
- Start date2009-10-21
- ConditionsHuman Papillomavirus Infection
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.